Study of a cannabis-based medicine for Tourette syndrome
Part of Brain & nervous system, Genetic & congenital, Mental health clinical trials.
This trial tests a new cannabis-based medicine, SCI-110, to see if it can reduce tics in adults with Tourette syndrome. It may offer a new treatment option for those whose tics are not well controlled.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with Tourette syndrome.
- Your tics are moderate to severe (scoring above 14 on a standard tic scale).
- Your current tic medications (if any) have been at the same dose for at least 6 weeks, and you agree to keep them stable during the study.
- You are willing to use reliable birth control (if you are a woman who can become pregnant) or use a condom (if you are a man) during the study and for 3 months after.
- You have not used cannabis or cannabis-based medicines in the 30 days before the study starts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a treatment called TMS, added to an evidence-based therapy called CBIT, can reduce Tourette’s tics more than CBIT alone. You may be assigned to different study groups, and they will also use brain imaging to measure changes.
This study tests a behavioral therapy (CBIT) for children with tics. It uses brain scans (MRI and EEG) to see how the therapy works. It may be a good fit for a child who has had tics for at least a year and hasn't had much of this therapy before.
This study tests whether combining a brain stimulation technique called TMS with behavioral therapy can reduce tics in adolescents and young adults. If you have had tics for at least a year and they are moderate or severe, this trial may be a good fit.
This study looks at brain activity in people with Tourette syndrome who are already receiving deep brain stimulation (a treatment that uses electrical pulses to help control tics). The goal is to learn more about the brain signals linked to tics, which could help improve future treatments.
This trial tests a surgical procedure using deep brain stimulation to treat severe Tourette syndrome that hasn't improved with other treatments. It may help reduce tics by targeting specific areas in the brain.
This trial tests a brain stimulation device (RNS) for people with Tourette's syndrome whose symptoms haven't improved with standard treatments. It aims to see if this approach can reduce tics and improve quality of life.
Hear when a new Tourette Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.